CGMP-MEDIATED VASODILATION IN PERINATAL LUNG
CGMP 介导的围产期肺血管舒张
基本信息
- 批准号:2693375
- 负责人:
- 金额:$ 29.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: In vascular smooth muscle cells, endothelium-derived NO, ANF,
nitrovasodilators and exogenous NO-induced vasodilation by activation of the
PKG cascade following increases in intracellular cGMP concentrations. The
NO-cGMP-PKG pathway plays a pivotal role in establishing low vascular
resistance in the pulmonary circulation. The applicant and others have been
studying this pathway and thus far has focused on studies of the enzymes
(guanylyl cyclase and phosphodiesterase) that regulate cGMP levels. Studies
ar now proposed to determine the mechanisms by which elevated cGMP in
vascular smooth muscle cells ultimately result in vasodilation in the
developing lung a the time of birth. Aim 1 will determine the role of PKG
in cGMP-mediated vasodilation and the link between the developmental
increase in cGMP-induced dilation in the perinatal period and PKG activity
will be explored. The specific roles of PKG type 1-alpha and 1-beta
isoforms will be determined. Aim 2 will determine the role of the protein
phosphatases, PP1 PP2A, and PP2B, in PKG-mediated vasodilation. Aim 3 will
determine the effect of oxygen tension o PKG and phosphatase activity in the
perinatal period. All studies will be conducted in the ovine species, and
isolated vessel tension experiments will b complemented with molecular and
biochemical studies in the experimental protocols. The investigators have
shown that responses of pulmonary arteries may be quite different from those
of veins, and experiments will therefore be done in both arteries and veins.
Any disturbance in the normal fall in pulmonary vascular resistance at birth
results in pulmonary hypertension of th newborn and significant morbidity
and mortality. Knowledge derived from these studies could lead to a better
understanding of the mechanisms of pulmonary vasodilation at birth and thus
to develop strategies to prevent and treat pulmonary hypertension in the
perinatal period.
在血管平滑肌细胞中,内皮源性NO、ANF、
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
J. Usha RAJ其他文献
J. Usha RAJ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('J. Usha RAJ', 18)}}的其他基金
Role of microRNA-17-92 and PDLIM5 Signaling in Pulmonary Arterial Hypertension
microRNA-17-92 和 PDLIM5 信号传导在肺动脉高压中的作用
- 批准号:
8964376 - 财政年份:2015
- 资助金额:
$ 29.75万 - 项目类别:
Role of microRNA-17-92 and PDLIM5 Signaling in Pulmonary Arterial Hypertension
microRNA-17-92 和 PDLIM5 信号传导在肺动脉高压中的作用
- 批准号:
9261587 - 财政年份:2015
- 资助金额:
$ 29.75万 - 项目类别:
MicroRNAs in Regulation of Pulmonary Vascular Smooth Muscle Cell Proliferation
MicroRNA 调控肺血管平滑肌细胞增殖
- 批准号:
8335483 - 财政年份:2011
- 资助金额:
$ 29.75万 - 项目类别:
MicroRNAs in Regulation of Pulmonary Vascular Smooth Muscle Cell Proliferation
MicroRNA 调控肺血管平滑肌细胞增殖
- 批准号:
8211933 - 财政年份:2011
- 资助金额:
$ 29.75万 - 项目类别:
Mechanism of cGMP-Mediated Vasodilation in Perinatal Lung
cGMP 介导的围产期肺血管舒张机制
- 批准号:
6866063 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
PAF and Hypoxia-Induced Pulmonary Hypertension
PAF 和缺氧引起的肺动脉高压
- 批准号:
7081273 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
PAF and Hypoxia-Induced Pulmonary Hypertension
PAF 和缺氧引起的肺动脉高压
- 批准号:
7236631 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
PAF and Hypoxia-Induced Pulmonary Hypertension
PAF 和缺氧引起的肺动脉高压
- 批准号:
7649774 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
PAF and Hypoxia-Induced Pulmonary Hypertension
PAF 和缺氧引起的肺动脉高压
- 批准号:
6821517 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
PAF and Hypoxia-Induced Pulmonary Hypertension
PAF 和缺氧引起的肺动脉高压
- 批准号:
6908146 - 财政年份:2004
- 资助金额:
$ 29.75万 - 项目类别:
相似海外基金
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10614436 - 财政年份:2022
- 资助金额:
$ 29.75万 - 项目类别:
Characterization of cyclic-GMP-cAMP regulation in Vibrio cholerae
霍乱弧菌中环 GMP-cAMP 调节的特征
- 批准号:
10371521 - 财政年份:2022
- 资助金额:
$ 29.75万 - 项目类别:
Roll of Nitrous Oxide (NO) and Cyclic GMP in Cancer
一氧化二氮 (NO) 和环 GMP 在癌症中的作用
- 批准号:
10513319 - 财政年份:2021
- 资助金额:
$ 29.75万 - 项目类别:
Roll of Nitrous Oxide (NO) and Cyclic GMP in Cancer
一氧化二氮 (NO) 和环 GMP 在癌症中的作用
- 批准号:
10256298 - 财政年份:2021
- 资助金额:
$ 29.75万 - 项目类别:
Cyclic GMP-dependent closure of an ion channel
依赖于循环 GMP 的离子通道关闭
- 批准号:
431444-2012 - 财政年份:2012
- 资助金额:
$ 29.75万 - 项目类别:
University Undergraduate Student Research Awards
Extracellular renal cyclic GMP mediates pressure-induced natriuresis
细胞外肾环 GMP 介导压力诱导的尿钠排泄
- 批准号:
7544807 - 财政年份:2008
- 资助金额:
$ 29.75万 - 项目类别:
Role of Nitric Oxide and Cyclic GMP in Stem Cells
一氧化氮和环鸟苷酸在干细胞中的作用
- 批准号:
7623532 - 财政年份:2007
- 资助金额:
$ 29.75万 - 项目类别:
Role of cyclic GMP in hepatic ischemia/reperfusion injury
环鸟苷酸在肝缺血/再灌注损伤中的作用
- 批准号:
19791088 - 财政年份:2007
- 资助金额:
$ 29.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Role of Nitric Oxide and Cyclic GMP in Stem Cells
一氧化氮和环鸟苷酸在干细胞中的作用
- 批准号:
7872757 - 财政年份:2007
- 资助金额:
$ 29.75万 - 项目类别:
A Novel HTS Cell-Based Assay For Cyclic GMP
一种新型 HTS 细胞循环 GMP 检测方法
- 批准号:
7292261 - 财政年份:2007
- 资助金额:
$ 29.75万 - 项目类别: